TG Therapeutics Inc (NASDAQ:TGTX)

15.79
Delayed Data
As of Mar 27
 -0.27 / -1.68%
Today’s Change
4.42
Today|||52-Week Range
20.00
-0.32%
Year-to-Date

Today’s Trading

Previous close16.06
Today’s open15.97
Day’s range15.67 - 16.63
Volume473,391
Average volume (3 months)609,056
Market cap$734.9M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-102.47%
Earnings growth (this year)+13.26%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales3,541.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SGNTSagent Pharmaceutica...-1.12-4.68%
EPZMEpizyme Inc+0.50+2.74%
INFIInfinity Pharmaceuti...-0.10-0.69%
FLMLFlamel Technologies ...+0.05+0.28%
Data as of 4:14pm ET, 03/27/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$152.4K
Annual profit (last year)-$55.8M
Net profit margin-36,606.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael S. Weiss
Chief Financial Officer, Treasurer &
Secretary
Sean A. Power
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account